Biofrontera Inc. Common Stock
BFRI Real Time Price USDRecent trades of BFRI by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by BFRI's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
-
$5,000 Jul 11, 2019 Issue: Health Issues
-
$5,000 Apr 16, 2019 Issue: Health Issues
-
$5,000 Jan 11, 2019 Issue: Health Issues
-
$5,000 Oct 19, 2018 Issue: Health Issues
Estimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
No new patents for this ticker
U.S. Patents DashboardFederal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of BFRI in WallStreetBets Daily Discussion
Recent insights relating to BFRI
Recent picks made for BFRI stock on CNBC
ETFs with the largest estimated holdings in BFRI
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BFRI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.